Golden Sun Health Technology Group Ltd. reported revenues from continuing operations of approximately USD 29.4 million for the full year ended September 30, 2025, representing a nearly fivefold increase. During the period, the company operated two principal business lines: tutorial services and e-commerce services. As of September 30, 2025, its education centers offered foreign language tutorial programs in less commonly taught languages such as Spanish and Japanese, as well as Gaokao repeater tutorial programs. A significant corporate development in the period was the sale of 100% equity interests in its subsidiary, Shanghai Golden Sun Gongyu Education Technology Co., Ltd., and related subsidiaries for a total consideration of approximately USD 0.7 million. The transaction, completed on July 21, 2025, met the criteria for classification as a discontinued operation, and related assets, liabilities, revenues, expenses, and cash flows have been retroactively reclassified as discontinued operations for all periods presented. The company highlighted the rapidly evolving nature of the education industry and noted that industry growth may be subject to substantial uncertainties, which could impact future performance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Golden Sun Health Technology Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-015723), on February 13, 2026, and is solely responsible for the information contained therein.